DeepMed Research

The Case Comprehensive Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Subsidiary

Established: 1826-01-01

Employees: 5K

Market Cap: -

Website: http://www.case.edu/cancer

Clinical Trials

Intraoperative Placement of Cesium-131 Permanent Interstitial Brachytherapy in Head and Neck Cancer

Early Phase 1

Completed

Conditions: Head and Neck Cancer
Head and Neck Squamous Cell Carcinoma

Interventions: Drug: Cesium 131

First Posted Date: 2016-06-09

Last Posted Date: 2020-12-23

Lead Sponsor: Case Comprehensive Cancer Center

Target Recruit Count: 15

Registration Number: NCT02794675

Locations: 🇺🇸
University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

Optimal Timing of Postoperative Magnetic Resonance Imaging (MRI) in Patients With Extradural Spinal

Not Applicable

Completed

Conditions: Spinal Tumor

Interventions: Device: Magnetic Resonance Imaging

First Posted Date: 2016-06-03

Last Posted Date: 2024-05-14

Lead Sponsor: Case Comprehensive Cancer Center

Target Recruit Count: 8

Registration Number: NCT02790294

Locations: 🇺🇸
Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

Apalutamide and Leuprolide in Intermediate and High-risk Prostate Cancer

Phase 2

Completed

Conditions: Prostate Cancer

Interventions: Drug: Leuprolide acetate
Drug: Apalutamide
Procedure: Radical prostatectomy

First Posted Date: 2016-05-12

Last Posted Date: 2022-06-21

Lead Sponsor: Case Comprehensive Cancer Center

Target Recruit Count: 54

Registration Number: NCT02770391

Locations: 🇺🇸
Cleveland Clinic, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

Feasibility Trial of the Modified Atkins Diet and Bevacizumab for Recurrent Glioblastoma

Early Phase 1

Completed

Conditions: Glioblastoma
Brain Tumor

Interventions: Drug: Bevacizumab
Behavioral: Modified Atkins Diet

First Posted Date: 2016-05-11

Last Posted Date: 2019-03-15

Lead Sponsor: Case Comprehensive Cancer Center

Target Recruit Count: 18

Registration Number: NCT02768389

Locations: 🇺🇸
OhioHealth Research and Innovation Institute, Columbus, Ohio, United States
🇺🇸
Cleveland Clinic Taussig Cancer Institute, Case Comprehensive cancer Center, Cleveland, Ohio, United States
🇺🇸
University Hospitals Cleveland Medical Center, Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

and more 1 locations

Physical Activity Intervention to Reduce Functional Health Disparities Among Breast Cancer Survivors

Not Applicable

Completed

Conditions: Breast Cancer
Physical Activity

Interventions: Behavioral: Aerobic Training - Fixed Schedule
Behavioral: Successful Survivorship Health Education and Support Group
Behavioral: Resistance Training - Fixed Schedule
Behavioral: Flexible support groups
Behavioral: Walking program
Behavioral: Aerobic Training - Flexible Schedule
Behavioral: Resistance Training - Flexible Schedule

First Posted Date: 2016-05-05

Last Posted Date: 2022-03-22

Lead Sponsor: Case Comprehensive Cancer Center

Target Recruit Count: 218

Registration Number: NCT02763228

Locations: 🇺🇸
Metro Health Medical Center, Cleveland, Ohio, United States
🇺🇸
University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States
🇺🇸
Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

Weight-based Dosing for Dense Weekly Paclitaxel and Carboplatin in Overweight Patients w/ Body Surface Area (BSA) > 2.0

Phase 2

Terminated

Conditions: Gynecologic Malignancies

Interventions: Drug: Paclitaxel
Drug: Carboplatin

First Posted Date: 2016-04-29

Last Posted Date: 2022-06-30

Lead Sponsor: Case Comprehensive Cancer Center

Target Recruit Count: 3

Registration Number: NCT02756013

Locations: 🇺🇸
Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

Pilot Study Evaluating the Role of Histopathology Correlation in Treatment Planning

Not Applicable

Completed

Conditions: Prostate Cancer

Interventions: Device: Uronav guided biopsy
Device: Magnetic resonance imaging

First Posted Date: 2016-02-12

Last Posted Date: 2022-06-30

Lead Sponsor: Case Comprehensive Cancer Center

Target Recruit Count: 5

Registration Number: NCT02681614

Locations: 🇺🇸
Case Comprehensive Cancer Center, Cleveland, Ohio, United States

Capecitabine + Bevacizumab in Patients With Recurrent Glioblastoma

Phase 1

Active, not recruiting

Conditions: Glioblastoma

Interventions: Drug: Capecitabine
Drug: Bevacizumab

First Posted Date: 2016-02-01

Last Posted Date: 2024-11-21

Lead Sponsor: Case Comprehensive Cancer Center

Target Recruit Count: 12

Registration Number: NCT02669173

Locations: 🇺🇸
Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

Online Information and Support for Distance Caregivers

Not Applicable

Completed

Conditions: Advanced Cancer

Interventions: Behavioral: Video-C
Behavioral: Web-Only
Behavioral: Nurse Coaching

First Posted Date: 2016-01-28

Last Posted Date: 2022-02-22

Lead Sponsor: Case Comprehensive Cancer Center

Target Recruit Count: 397

Registration Number: NCT02666183

Locations: 🇺🇸
University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

Rational EpigenetiC Immunotherapy for SEcond Line Therapy in Patients With NSCLC: PRECISE Trial

Phase 2

Active, not recruiting

Conditions: Lung Cancer
Non-small Cell Lung Cancer

Interventions: Drug: Nivolumab
Drug: oral decitabine
Drug: Tetrahydrouridine

First Posted Date: 2016-01-26

Last Posted Date: 2024-07-03

Lead Sponsor: Case Comprehensive Cancer Center

Target Recruit Count: 13

Registration Number: NCT02664181

Locations: 🇺🇸
Center for Cancer Research, Bethesda, Maryland, United States
🇺🇸
Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy